• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Fischer’s financial slump continues in Q2

Article

Fischer Imaging of Denver continues to drift in financial doldrums. Despite increases in its second-quarter 1999 (end-July) revenues—the company posted $16.7 million for the quarter, up 9% from $15.2 million for the same period the previous

Fischer Imaging of Denver continues to drift in financial doldrums. Despite increases in its second-quarter 1999 (end-July) revenues—the company posted $16.7 million for the quarter, up 9% from $15.2 million for the same period the previous year—Fischer sustained a net loss for the quarter of approximately $2 million, including a restructuring charge. Without the charge, the company’s net loss was $1.2 million, compared to $984,000 in 1998.

Fischer’s moderate sales growth for the period was due to increases in mammography and service revenues offset by reductions in OEM shipments, according to vice president of finance Bill Fee. Its operating results for the quarter were disappointing, Fee said: Manufacturing variances were high, while production hours were lower than the year before. The $700,000 restructuring charge occurred when Fischer discontinued a product line manufactured at one of its facilities that the company was unable to relocate to Denver. In an effort to cut operating costs, the company reduced its inventory by more than $3 million, and last month cut its staff by 5%.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.